Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsIntensity Therapeutics, Inc. announced that the first US patient has been dosed in the Company’s Phase IIIstudy to treat metastatic sarcoma.
[Intensity Therapeutics, Inc.]
Home Newsletters Mesenchymal Cell News Intensity Therapeutics, Inc. Announces First Patient Dosed in its Global Randomized, Phase...
